ME Gleave

Latest

• BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
• BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer
• Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer